pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Microbiotica was launched in December 2016 with the aim of creating a global leader to exploit the leading microbiome science built at the Wellcome Trust Sanger Institute.
LOCATION
Cambridge, , UK
THERAPEUTIC AREAS
Gastrointestinal Disease
Infectious Disease
Inflammatory Disease
Oncology
WEBSITE
https://microbiotica.com
CAREER WEBSITE
https://www.microbiotica.com/careers
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Apr 12, 2023
Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA (pembrolizumab) in a Phase 1b Clinical Trial in Melanoma
Nov 29, 2022
Microbiotica Announces Transition of Leadership
Mar 7, 2022
Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics
Jun 23, 2021
Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology
Jun 8, 2020
Microbiotica, Cancer Research UK and Cambridge University Hospitals Collaborate in Landmark Cancer Microbiome Study
For More Press Releases